Phibro Animal Health | PAHC - Ebitda


Phibro Animal Health reported $68.1M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Align Technology USD 229.14M 31.74M Mar/2026
ANI Pharmaceuticals USD 71.6M 6.69M Jun/2026
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Bristol-Myers Squibb USD 4.24B 1.37B Mar/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Corcept Therapeutics USD -49M 53.2M Mar/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Henry Schein USD 288M 1000K Jun/2026
Idexx Laboratories USD 468.46M 67.59M Jun/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Merck USD -1.54B 7.84B Mar/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Pacira USD 48.67M 8.43M Jun/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 61.24M 23.31M Jun/2026
Supernus Pharmaceuticals USD 31.6M 2.37M Jun/2026
Zoetis USD 939M 0 Mar/2026